160 related articles for article (PubMed ID: 10936067)
1. Apoptosis and the liver.
Kanzler S; Galle PR
Semin Cancer Biol; 2000 Jun; 10(3):173-84. PubMed ID: 10936067
[TBL] [Abstract][Full Text] [Related]
2. [Apoptosis and liver diseases].
Joulin V
C R Seances Soc Biol Fil; 1998; 192(6):1077-94. PubMed ID: 10101604
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
4. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T
Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938
[TBL] [Abstract][Full Text] [Related]
5. Messengers of cell death: apoptotic signaling in health and disease.
Rossi D; Gaidano G
Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways.
Yin XM
Cell Res; 2000 Sep; 10(3):161-7. PubMed ID: 11032168
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in liver disease.
Schattenberg JM; Galle PR; Schuchmann M
Liver Int; 2006 Oct; 26(8):904-11. PubMed ID: 16953829
[TBL] [Abstract][Full Text] [Related]
8. Liver and apoptosis.
Valente M; Calabrese F
Ital J Gastroenterol Hepatol; 1999; 31(1):73-7. PubMed ID: 10091108
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and necrosis in the liver: a tale of two deaths?
Malhi H; Gores GJ; Lemasters JJ
Hepatology; 2006 Feb; 43(2 Suppl 1):S31-44. PubMed ID: 16447272
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
13. The Bcl-2 protein family and its role in the development of neoplastic disease.
Heiser D; Labi V; Erlacher M; Villunger A
Exp Gerontol; 2004 Aug; 39(8):1125-35. PubMed ID: 15288687
[TBL] [Abstract][Full Text] [Related]
14. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts.
Crowston JG; Chang LH; Constable PH; Daniels JT; Akbar AN; Khaw PT
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):692-9. PubMed ID: 11867586
[TBL] [Abstract][Full Text] [Related]
17. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
18. Death receptor-mediated liver injury.
Akazawa Y; Gores GJ
Semin Liver Dis; 2007 Nov; 27(4):327-38. PubMed ID: 17979070
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
